Author

Namita Nabar

Broad InstituteORCID 0000-0002-5159-4211Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Paula Therese HammondiD· 2 shared Tamara G. DacobaiD· 2 shared Adam G. BergeriD· 1 shared Chau Vo· 1 shared Elen Torres-MejiaiD· 1 shared John Christopher LoveiD· 1 shared Nicolas Mathey‐AndrewsiD· 1 shared Sean-Luc ShanahaniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Paula Therese HammondORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Modeling lung adenocarcinoma using layer-by-layer nanoparticles mitigates innate immune cell activation

Vidit Bhandarkar, Elen Torres-Mejia, Taylor A. Heim, Namita Nabar, Tamara G. Dacoba, Zachary J. Rogers, Nicolas Mathey‐Andrews, Sean-Luc Shanahan, Chau Vo, Adam G. Berger, John Christopher Love, Tyler Jacks, Paula Therese Hammond, Stefani Spranger

This paper develops a nanoparticle-based method to deliver Cre mRNA for lung adenocarcinoma modeling in mice, avoiding immune activation and enabling accurate tumor-immune dynamics studies.

bioRxiv · Sep 20, 2026 · PreprintImmunology

A Modular Layer-by-Layer Nanoparticle Platform for Hematopoietic Progenitor and Stem Cell Targeting

Tamara G. Dacoba, Namita Nabar, Paula Therese Hammond

This paper develops a modular LbL NP platform for targeting HSPCs and demonstrates its efficacy in both murine and human cells.

ACS Nano · Mar 13, 2025Peer-reviewedBioengineering